Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

234

Citations

24

References

2015

Year

Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman, Marian H. Harris, Sarah K. Hunt, Jane E. O’Brien, Jeffrey G. Supko, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell,

The Lancet Oncology

MedicineMicrobiologyOpen-label Phase 3Dfci 05-001

References

	Year	Citations

Page 1